Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 67 results.
User Information
Export Records
  1. 1.   Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
  2. Wang, Hua; Cheng, Cheng; Dal Santo, James L; Shen, Chen-Hsiang; Bylund, Tatsiana; Henry, Amy R; Howe, Colin A; Hwang, Juyun; Morano, Nicholas C; Morris, Daniel J; Pletnev, Sergei; Roark, Ryan S; Zhou, Tongqing; Hansen, Bryan T; Hoyt, Forrest H; Johnston, Timothy S; Wang, Shuyi; Zhang, Baoshan; Ambrozak, David R; Becker, Jordan E; Bender, Michael F; Changela, Anita; Chaudhary, Ridhi; Corcoran, Martin; Corrigan, Angela R; Foulds, Kathryn E; Guo, Yicheng; Lee, Myungjin; Li, Yingying; Lin, Bob C; Liu, Tracy; Louder, Mark K; Mandolesi, Marco; Mason, Rosemarie D; McKee, Krisha; Nair, Vinod; O'Dell, Sijy; Olia, Adam S; Ou, Li; Pegu, Amarendra; Raju, Nagarajan; Rawi, Reda; Roberts-Torres, Jesmine; Sarfo, Edward K; Sastry, Mallika; Schaub, Andrew J; Schmidt, Stephen D; Schramm, Chaim A; Schwartz, Cindi L; Smith, Sarah C; Stephens,Tyler; Stuckey, Jonathan; Teng, I-Ting; Todd, John-Paul; Tsybovsky,Yaroslav; Van Wazer, David J; Wang, Shuishu; Doria-Rose, Nicole A; Fischer, Elizabeth R; Georgiev, Ivelin S; Karlsson Hedestam, Gunilla B; Sheng, Zizhang; Woodward, Ruth A; Douek, Daniel C; Koup, Richard A; Pierson, Theodore C; Shapiro, Lawrence; Shaw, George M; Mascola, John R; Kwong, Peter D
  3. Cell. 2024, Oct 23;
  1. 2.   Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformation
  2. Zhang, Peng; Gorman, Jason; Tsybovsky,Yaroslav; Lu, Maolin; Liu, Qingbo; Gopan, Vinay; Singh, Mamta; Lin, Yin; Miao, Huiyi; Seo, Yuna; Kwon, Alice; Olia, Adam S; Chuang, Gwo-Yu; Geng, Hui; Lai, Yen-Ting; Zhou, Tongqing; Mascola, John R; Mothes, Walther; Kwong, Peter D; Lusso, Paolo
  3. Cell Reports. 2024, Jul 18; 43(8): 114518.
  1. 3.   Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays
  2. Hu, Zhe; López-Muñoz, Alberto Domingo; Kosik, Ivan; Li, Tiansheng; Callahan, Victoria; Brooks, Kelsie; Yee, Debra S; Holly, Jaroslav; Santos, Jefferson J S; Castro Brant,Ayslan; Johnson, Reed F; Takeda, Kazuyo; Zheng,Zhi-Ming; Brenchley, Jason M; Yewdell, Jonathan W; Fox, Julie M
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Jul 16; 121(29): e2310421121.
  1. 4.   Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles
  2. Zhang, Peng; Falcone, Samantha; Tsybovsky,Yaroslav; Singh, Mamta; Gopan, Vinay; Miao, Huiyi; Seo, Yuna; Rogers, Denise; Renzi, Isabella; Lai, Yen-Ting; Narayanan, Elisabeth; Stewart-Jones, Guillaume; Himansu, Sunny; Carfi, Andrea; Fauci, Anthony S; Lusso, Paolo
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jul 18; 120(29): e2305896120.
  1. 5.   Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
  2. Lam, Alex K; Roshan,Romin; Miley,Wendell; Labo, Nazzarena; Zhen, James; Kurland, Andrew P; Cheng, Celine; Huang, Haigen; Teng, Pu-Lin; Harelson, Claire; Gong, Danyang; Tam, Ying K; Radu, Caius G; Epeldegui, Marta; Johnson, Jeffrey R; Zhou, Z Hong; Whitby,Denise; Wu, Ting-Ting
  3. Journal of Virology. 2023, Feb 09; e0160022.
  1. 6.   Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2
  2. Gao, Nan; Gai, Yanxin; Meng, Lina; Wang, Chu; Wang, Wei; Li, Xiaojun; Gu, Tiejun; Louder, Mark K; Doria-Rose, Nicole A; Wiehe, Kevin; Nazzari, Alexandra F; Olia, Adam S; Gorman, Jason; Rawi, Reda; Wu, Wenmin; Smith, Clayton; Khant, Htet; de Val, Natalia; Yu, Bin; Luo, Junhong; Niu, Haitao; Tsybovsky, Yaroslav; Liao, Huaxin; Kepler, Thomas B; Kwong, Peter D; Mascola, John R; Qin, Chuan; Zhou, Tongqing; Yu, Xianghui; Gao, Feng
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2022, Mar 23; e2200063.
  1. 7.   A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
  2. Zhang, Peng; Narayanan, Elisabeth; Liu, Qingbo; Tsybovsky, Yaroslav; Boswell, Kristin; Ding, Shilei; Hu, Zonghui; Follmann, Dean; Lin, Yin; Miao, Huiyi; Schmeisser, Hana; Rogers, Denise; Falcone, Samantha; Elbashir, Sayda M.; Presnyak, Vladimir; Bahl, Kapil; Prabhakaran, Madhu; Chen, Xuejun; Sarfo, Edward K.; Ambrozak, David R.; Gautam, Rajeev; Martin, Malcom A.; Swerczek, Joanna; Herbert, Richard; Weiss, Deborah; Misamore, Johnathan; Ciaramella, Giuseppe; Himansu, Sunny; Stewart-Jones, Guillaume; McDermott, Adrian; Koup, Richard A.; Mascola, John R.; Finzi, Andres; Carfi, Andrea; Fauci, Anthony S.; Lusso, Paolo
  3. Nature Medicine. 2021, Dec;
  1. 8.   Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
  2. Crooks, Emma T.; Almanza, Francisco; D'Addabbo, Alessio; Duggan, Erika; Zhang, Jinsong; Wagh, Kshitij; Mou, Huihui; Allen, Joel D.; Thomas, Alyssa; Osawa, Keiko; Korber, Bette T.; Tsybovsky,Yaroslav; Cale, Evan; Nolan, John; Crispin, Max; Verkoczy, Laurent K.; Binley, James M.
  3. PLoS Pathogens. 2021, Oct; 17(10):
  1. 9.   SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
  2. Olia, Adam S.; Tsybovsky,Yaroslav; Chen, Steven J.; Liu, Cuiping; Nazzari, Alexandra F.; Ou, Li; Wang, Lingshu; Kong, Wing-Pui; Leung, Kwan; Liu, Tracy; Stephens,Tyler; Teng, I-Ting; Wang, Shuishu; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Zhou, Tongqing; Mascola, John R.; Kwong, Peter D.
  3. The Journal of biological chemistry. 2021, Oct; 297(4):
  1. 10.   A Retrospective Survey among SARS-CoV-1 Infected Healthcare Workers after Three Years Post-Infection
  2. Huang,Szu-Wei; Urbina, Aspiro Nayim; Chen, Yi-Ming Arthur; Wang, Sheng-Fan
  3. Pathogens. 2021, Aug 25; 10(9):
  1. 11.   Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B ' Infected Plasma Donor with Broadly Neutralizing Activity
  2. Hu, Yuanyuan; Zou, Sen; Wang, Zheng; Liu, Ying; Ren, Li; Hao, Yanling; Sun, Shasha; Hu, Xintao; Ruan, Yuhua; Ma, Liying; Shao, Yiming; Hong, Kunxue
  3. Vaccines. 2021, Apr; 9(4):
  1. 12.   Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria
  2. Francica, Joseph R.; Shi, Wei; Chuang, Gwo-Yu; Chen, Steven J.; Da Silva Pereira, Lais; Farney, S. Katie; Flynn, Barbara J.; Ou, Li; Stephens, Tyler; Tsybovsky,Yaroslav; Wang, Lawrence T.; Anderson, Alexander; Beck, Zoltan; Dillon, Marlon; Idris, Azza H.; Hurlburt, Nicholas; Liu, Tracy; Zhang, Baoshan; Alving, Carl R.; Matyas, Gary R.; Pancera, Marie; Mascola, John R.; Kwong, Peter D.; Seder, Robert A.
  3. Vaccines. 2021, Mar 18; 9(3):
  1. 13.   Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
  2. Thomopoulos, Thomas P; Rosati,Margherita; Terpos, Evangelos; Stellas, Dimitris; Hu, Xintao; Karaliota, Sevasti; Bouchla, Anthi; Katagas, Ioannis; Antoniadou, Anastasia; Mentis, Andreas; Papageorgiou, Sotirios G; Politou, Marianna; Bear,Jenifer; Donohue,Duncan; Kotanidou, Anastasia; Kalomenidis, Ioannis; Korompoki, Eleni; Burns,Robert; Pagoni, Maria; Grouzi, Elisavet; Labropoulou, Stavroula; Stamoulis, Kostantinos; Bamias, Aristotelis; Tsiodras, Sotirios; Dimopoulos, Meletios-Athanasios; Pavlakis,George; Pappa, Vasiliki; Felber,Barbara
  3. Viruses. 2021, 09 15; 13(9):
  1. 14.   Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
  2. Zhou, Tongqing; Teng, I-Ting; Olia, Adam S; Cerutti, Gabriele; Gorman, Jason; Nazzari, Alexandra; Shi, Wei; Tsybovsky,Yaroslav; Wang, Lingshu; Wang, Shuishu; Zhang, Baoshan; Zhang, Yi; Katsamba, Phinikoula S; Petrova, Yuliya; Banach, Bailey B; Fahad, Ahmed S; Liu, Lihong; Lopez Acevedo, Sheila N; Madan, Bharat; Oliveira de Souza, Matheus; Pan, Xiaoli; Wang, Pengfei; Wolfe, Jacy R; Yin, Michael; Ho, David D; Phung, Emily; DiPiazza, Anthony; Chang, Lauren A; Abiona, Olubukola M; Corbett, Kizzmekia S; DeKosky, Brandon J; Graham, Barney S; Mascola, John R; Misasi, John; Ruckwardt, Tracy; Sullivan, Nancy J; Shapiro, Lawrence; Kwong, Peter D
  3. Cell reports. 2020, Oct 27; 33(4): 108322.
  1. 15.   Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
  2. Cheung, Crystal Sao-Fong; Fruehwirth, Alexander; Paparoditis, Philipp Carl Georg; Shen, Chen-Hsiang; Foglierini, Mathilde; Joyce, M Gordon; Leung, Kwanyee; Piccoli, Luca; Rawi, Reda; Silacci-Fregni, Chiara; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Lingshu; Wang, Shuishu; Yang, Eun Sung; Zhang, Baoshan; Zhang, Yi; Chuang, Gwo-Yu; Corti, Davide; Mascola, John R; Shapiro, Lawrence; Kwong, Peter D; Lanzavecchia, Antonio; Zhou, Tongqing
  3. Cell reports. 2020, Sep 01; 32(9): 108088.
  1. 16.   Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
  2. Seabright, Gemma E; Cottrell, Christopher A; van Gils, Marit J; D'addabbo, Alessio; Harvey, David J; Behrens, Anna-Janina; Allen, Joel D; Watanabe, Yasunori; Scaringi, Nicole; Polveroni, Thomas M; Maker, Allison; Vasiljevic, Snezana; De Val Alda,Natalia; Sanders, Rogier W; Ward, Andrew B; Crispin, Max
  3. Structure (London, England : 1993). 2020, AUG 4; 28(8): 897-+.
  1. 17.   Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
  2. Asokan, Mangaiarkarasi; Dias, Joana; Liu, Cuiping; Maximova, Anna; Ernste, Keenan; Pegu, Amarendra; McKee, Krisha; Shi, Wei; Chen, Xuejun; Almasri, Cassandra; Promsote, Wanwisa; Ambrozak, David R; Gama, Lucio; Hu, Jianfei; Douek, Daniel C; Todd, John-Paul; Lifson,Jeffrey; Fourati, Slim; Sekaly, Rafick P; Crowley, Andrew R; Ackerman, Margaret E; Ko, Sung Hee; Kilam, Divya; Boritz, Eli A; Liao, Laura E; Best, Katharine; Perelson, Alan S; Mascola, John R; Koup, Richard A
  3. Proceedings of the National Academy of Sciences of the United States of America. 2020, AUG 4; 117(31): 18754-18763.
  1. 18.   Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
  2. Martinez-Navio, José M; Fuchs, Sebastian P; Mendes, Desiree E; Rakasz, Eva G; Gao, Guangping; Lifson,Jeffrey; Desrosiers, Ronald C
  3. Frontiers in immunology. 2020, MAR 17; 11: 449.
  1. 19.   Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
  2. Pedreno-Lopez, Nuria; Dang, Christine M.; Rosen, Brandon C.; Ricciardi, Michael J.; Bailey, Varian K.; Gutman, Martin J.; Gonzalez-Nieto, Lucas; Pauthner, Matthias G.; Song, Ge; Andrabi, Raiees; Weisgrau, Kim L.; Pomplun, Nicholas; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Wrammert, Jens; Rakasz, Eva G.; Lifson,Jeffrey; Martins, Mauricio A.; Burton, Dennis R.; Watkins, David; Magnani, Diogo M.
  3. Molecular therapy. Methods & clinical development. 2020, Mar 13; 16: 225-237.
  1. 20.   Adeno-associated viral vector mediated expression of broadly-neutralizing antibodies against HIV - hitting a fast-moving target
  2. Sherpa,Chringma; Le Grice,Stuart
  3. Current HIV research. 2020, Feb 10; 18(2): 114-131.
  1. 21.   Rapid elimination of broadly neutralizing antibodies correlates with treatment failure in the acute phase of SHIV infection
  2. Wu, Yanling; Xue, Jing; Wang, Chunyu; Li, Wei; Wang, Lili; Chen, Weizao; Prabakaran, Ponraj; Kong, Desheng; Jin, Yujia; Hu, Dan; Wang, Yulu; Lei, Cheng; Yu, Diao; Tu, Chao; Bardhi, Ariola; Sidorov, Igor; Ma, Liying; Goldstein, Harris; Qin, Chuan; Lu, Lu; Jiang, Shibo; Dimitrov, Dimiter S; Ying, Tianlei
  3. Journal of virology. 2019, OCT; 93(20): pii: JVI.01077-19. .
  1. 22.   Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
  2. Anthony-Gonda, Kim; Bardhi, Ariola; Ray, Alex; Flerin, Nina; Li, Mengyan; Chen, Weizao; Ochsenbauer, Christina; Kappes, John C; Krueger, Winfried; Worden, Andrew; Schneider, Dina; Zhu, Zhongyu; Orentas, Rimas; Dimitrov, Dimiter S; Goldstein, Harris; Dropulic, Boro
  3. Science translational medicine. 2019, Aug 07; 11(504): pii: eaav5685..
  1. 23.   Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
  2. Martinez-Navio, José M; Fuchs, Sebastian P; Pantry, Shara N; Lauer, William A; Duggan, Natasha N; Keele, Brandon; Rakasz, Eva G; Gao, Guangping; Lifson, Jeffrey; Desrosiers, Ronald C
  3. Immunity. 2019, Mar 19; 50(3): 567-+.
  1. 24.   Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer
  2. Zhang, Peng; Gorman, Jason; Geng, Hui; Liu, Qingbo; Lin, Yin; Tsybovsky, Yaroslav; Go, Eden P; Dey, Barna; Andine, Tsion; Kwon, Alice; Patel, Mit; Gururani, Deepali; Uddin, Ferzan; Guzzo, Christina; Cimbro, Raffaello; Miao, Huiyi; McKee, Krisha; Chuang, Gwo-Yu; Martin, Loïc; Sironi, Francesca; Malnati, Mauro S; Desaire, Heather; Berger, Edward A; Mascola, John R; Dolan, Michael A; Kwong, Peter D; Lusso, Paolo
  3. Cell Host & Microbe. 2018, Jun 13; 23(6): 832-844.e6.
  1. 25.   The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells
  2. Alexandre, K. B.; Gray, E. S.; Mufhandu, H.; McMahon, J. B.; Chakauya, E.; O'Keefe, B. R.; Chikwamba, R.; Morris, L.
  3. Virology. 2012, Feb; 423(2): 175-186.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel